BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 9371627)

  • 1. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony.
    Leroux C; Issel CJ; Montelaro RC
    J Virol; 1997 Dec; 71(12):9627-39. PubMed ID: 9371627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.
    Leroux C; Craigo JK; Issel CJ; Montelaro RC
    J Virol; 2001 May; 75(10):4570-83. PubMed ID: 11312327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus.
    Lichtenstein DL; Issel CJ; Montelaro RC
    J Virol; 1996 Jun; 70(6):3346-54. PubMed ID: 8648664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.
    Howe L; Leroux C; Issel CJ; Montelaro RC
    J Virol; 2002 Nov; 76(21):10588-97. PubMed ID: 12368301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony.
    Belshan M; Baccam P; Oaks JL; Sponseller BA; Murphy SC; Cornette J; Carpenter S
    Virology; 2001 Jan; 279(1):185-200. PubMed ID: 11145901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: insertions/duplications at the principal neutralizing domain.
    Zheng YH; Sentsui H; Nakaya T; Kono Y; Ikuta K
    J Virol; 1997 Jul; 71(7):5031-9. PubMed ID: 9188568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication.
    Craigo JK; Leroux C; Howe L; Steckbeck JD; Cook SJ; Issel CJ; Montelaro RC
    J Gen Virol; 2002 Jun; 83(Pt 6):1353-1359. PubMed ID: 12029150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus.
    Cook RF; Leroux C; Cook SJ; Berger SL; Lichtenstein DL; Ghabrial NN; Montelaro RC; Issel CJ
    J Virol; 1998 Feb; 72(2):1383-93. PubMed ID: 9445039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune selection of equine infectious anemia virus env variants during the long-term inapparent stage of disease.
    Sponseller BA; Sparks WO; Wannemuehler Y; Li Y; Antons AK; Oaks JL; Carpenter S
    Virology; 2007 Jun; 363(1):156-65. PubMed ID: 17328936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.
    Hammond SA; Li F; McKeon BM; Cook SJ; Issel CJ; Montelaro RC
    J Virol; 2000 Jul; 74(13):5968-81. PubMed ID: 10846078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertions, duplications and substitutions in restricted gp90 regions of equine infectious anaemia virus during febrile episodes in an experimentally infected horse.
    Zheng YH; Nakaya T; Sentsui H; Kameoka M; Kishi M; Hagiwara K; Takahashi H; Kono Y; Ikuta K
    J Gen Virol; 1997 Apr; 78 ( Pt 4)():807-20. PubMed ID: 9129653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique evolution characteristics of the envelope protein of EIAV(LN₄₀), a virulent strain of equine infectious anemia virus.
    Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Zhou J
    Virus Genes; 2011 Apr; 42(2):220-8. PubMed ID: 21369830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.
    Harrold SM; Cook SJ; Cook RF; Rushlow KE; Issel CJ; Montelaro RC
    J Virol; 2000 Apr; 74(7):3112-21. PubMed ID: 10708426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation of envelope gp90 gene of equine infectious anemia virus isolated from an experimentally infected horse.
    Pang H; Kong XG; Sentsui H; Kono Y; Sugiura T; Hasegawa A; Akashi H
    J Vet Med Sci; 1997 Dec; 59(12):1089-95. PubMed ID: 9450237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease induction by virus derived from molecular clones of equine infectious anemia virus.
    Payne SL; Qi XM; Shao H; Dwyer A; Fuller FJ
    J Virol; 1998 Jan; 72(1):483-7. PubMed ID: 9420249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity.
    Lichtenstein DL; Rushlow KE; Cook RF; Raabe ML; Swardson CJ; Kociba GJ; Issel CJ; Montelaro RC
    J Virol; 1995 May; 69(5):2881-8. PubMed ID: 7707512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep sequencing and variant analysis of an Italian pathogenic field strain of equine infectious anaemia virus.
    Cappelli K; Cook RF; Stefanetti V; Passamonti F; Autorino GL; Scicluna MT; Coletti M; Verini Supplizi A; Capomaccio S
    Transbound Emerg Dis; 2017 Dec; 64(6):2104-2112. PubMed ID: 28299895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Equine Infectious Anemia Virus Long Terminal Repeat Quasispecies
    Wang XF; Liu Q; Wang YH; Wang S; Chen J; Lin YZ; Ma J; Zhou JH; Wang X
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29386282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
    Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC
    Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine.
    Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J
    Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.